Daily Alcohol Intake Raises Health Risks Contrary to Current U.S. Guidelines

A new modeling analysis in the Journal of Studies on Alcohol and Drugs, drawing on 56 systematic reviews and meta-analyses plus federal datasets, estimates that alcohol-attributable mortality risk exceeds 1 in 1,000 at just 6.5 drinks weekly for men and 7 for women—well below prior U.S. thresholds. This observational synthesis, not an RCT, highlights no net health benefit even at low levels while linking modest intake to elevated cancer risks in breast, colorectal, and liver sites. Unlike single-cohort studies, the approach aggregates mortality records and consumption surveys but inherits limitations from heterogeneous meta-analyses and potential underreporting biases. The findings clash with lingering 2-drink male allowances, a discrepancy tied to shifts between Biden- and Trump-era guideline processes. Parallel evidence from the 2018 Lancet GBD study reinforces dose-dependent harms across 195 countries, showing J-shaped curves largely disappear after bias correction. Binge patterns amplify acute events beyond volume alone, an angle the Healthline piece underplays. For millions weighing nightly pours, this underscores reevaluating social norms against accumulating cancer and mortality data.